Table 3 Association between MYEF2 expression and pathological parameters of patients
From: Expression and function of myelin expression factor 2 in hepatocellular carcinoma
Pathological parameter | MYEF2 expression | P-value | |
|---|---|---|---|
High | Low | ||
All cases | 93 | 48 | |
Gender | 0.964 | ||
Male | 72 (77.8%) | 37 (78.1%) | |
Female | 21 (22.2%) | 11 (21.8%) | |
Age (years) | 0.423 | ||
≤ 56 | 55 (58.7%) | 25 (53.1%) | |
> 56 | 38 (41.3) | 23 (46.9%) | |
P53 expression | 0.224 | ||
Low expression | 31 (33.3%) | 21 (43.8%) | |
High expression | 62 (66.7%) | 27 (56.2%) | |
CK19 expression | 0.614 | ||
Low expression | 64 (68.3%) | 35 (71.9%) | |
High expression | 29 (31.7%) | 13 (28.1%) | |
Hepatocyte expression | 0.110 | ||
Low expression | 50 (54.0%) | 19 (40.6%) | |
High expression | 43 (46.0%) | 29 (59.4%) | |
Gly-3 expression | 0.004 | ||
Low expression | 29 (31.7%) | 27 (56.2%) | |
High expression | 64 (68.3%) | 21 (43.8%) | |
Arg-1 expression | 0.278 | ||
Low expression | 61 (65.1%) | 27 (56.2%) | |
High expression | 32 (34.9%) | 21 (43.8%) | |
AFP expression | 0.029 | ||
Low expression | 29 (31.7%) | 24 (50.0%) | |
High expression | 64 (68.3%) | 24 (50.0%) | |
Vascular invasion | 0.725 | ||
Negative | 59 (64.3%) | 29 (60.4%) | |
Positive | 34 (35.7%) | 19 (39.6%) | |